OpenDDE is a preview release. CLI flags, input/output JSON fields, and released checkpoints may change between versions, and predictions are not guaranteed to be reproducible across releases. It is ...
“Honestly, AI slop [pull requests] are becoming increasingly draining and demoralizing for #Godot maintainers,” Verschelde ...
"If we improve the code and we can all benefit from it, it's good for everyone," says Fenris's Ben Hunter, as he talks ...
The Godot Foundation have announced a crackdown on genAI code, including mandatory disclosures, following a wave of ...
You can probably guess what Batman movie is considered the best by the users of IMDb, but there are some surprising entries ...
Luigi Mangione, the man accused of killing UnitedHealthcare CEO Brian Thompson, plans to pursue a psychiatric defense in his state murder trial, a judge revealed Wednesday. New York Judge Gregory ...
Luigi Mangione will assert a psychiatric defense in his state murder trial in the killing of UnitedHealthcare CEO Brian Thompson, the New York judge overseeing the case said at a hearing Wednesday.
June 17 (UPI) --Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, will assert in the state case against him that he was suffering from "extreme emotional disturbance" at the time ...
Luigi Mangione’s attorneys will present a psychiatric defense at his state murder trial this fall, arguing he killed UnitedHealthcare chief executive Brian Thompson while suffering an extreme ...
Luigi Mangione plans to assert a psychiatric defense at his state murder trial after he was accused of killing UnitedHealthcare CEO Brian Thompson in 2024. New York Judge Gregory Carro said on ...
Wednesday is the hands-on day at WWDC 2026. Group Labs for Xcode 27, Foundation Models, Core AI, App Intents, and the parental-control API stack are running today, June 10, at Apple Park — the last ...
The Levasseurs took out a second mortgage on their home and drained their savings, desperate to keep their older daughter in treatment. It took seven years for Rachel Levasseur to find a treatment ...